Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748771 · ClinicalTrials.gov registry record
Validation of ApneaLink Air Home Sleep Testing in the Diagnosis of Obstructive Sleep Apnea in Adolescent Children
A clinical trial, sponsored by ResMed.
- Completed
- Registry status
- 20
- Enrollment target
NCT03748771 is a clinical trial that has completed, run by ResMed. The registered enrollment target is 20 participants.
The verdict
NCT03748771 has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The feasibility and the validity of the ApneaLink Air home sleep testing (HST) device will be tested in adolescent children. The ApneaLink Air HST device is cleared for the diagnosis of obstructive sleep apnea (OSA) in adults..
Interventions
- DEVICE ApneaLink Air
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03748771
The ClinicalTrials.gov registry entry for NCT03748771 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ApneaLink Air is the first listed.
NCT03748771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03748771 about?
NCT03748771 is a clinical study titled "Validation of ApneaLink Air Home Sleep Testing in the Diagnosis of Obstructive Sleep Apnea in Adolescent Children". The feasibility and the validity of the ApneaLink Air home sleep testing (HST) device will be tested in adolescent children. The ApneaLink Air HST device is cleared for the diagnosis of obstructive sleep apnea (OSA) in adults..
What is the current status of trial NCT03748771?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-12-01. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03748771?
The interventions under investigation include: ApneaLink Air (DEVICE).
Who is sponsoring clinical trial NCT03748771?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.